HANDBOOK OF BIOLOGICS FOR RHEUMATOLOGICAL DISORDERS

• History of Biologics
• Biologics in Rheumatoid Arthritis
• Biologics in Spondylarthritis
• Biologics in Psoriatic Arthritis
• Biologics in Gout
• Biologics in Lupus
• Biologics in Sjogren’s Syndrome
• Biologics in Systemic Sclerosis
• Biologics in Inflammatory Myopathies
• Biologics in ANCA Associated Vasculitis
• Biologics inBehcet's Syndrome
• Biologicsin Takayasu's Arteritis
• Biologics in Interstitial lung disease in Rheumatological conditions
• Biologics in Osteoporosis
• Biologics in Osteoarthritis
• Biologics in JIA
• Biologics in Paediatric CTD
• JAK inhibitors in Rheumatology
• Biologics in Rheumatic disease with Infections
• Biologics in Rheumatological conditions with Malignancy
• Biologics in Uveitis
• Biologics in Sarcoidosis
• Biologics in IgG4-RD
• Biosimilar in Rheumatology
• Off label use of Biologics in Rheumatological disorders
• Biologics & Ethical issues in Rheumatology
• Patient consent for use of biologics.

This book provides an inclusive approach with the existing evidence concerning effectiveness, cost, and its implications on using biologics in treating various rheumatologic disorders. It also covers the evidence behind the rational use of biological agents in varied autoimmune diseases. This book also offers a complete overview of the existing and futuristic biologic treatments and to draws a recommendation on how to standardize the most suitable regimen for a specific patient in the context of current guidelines.
Biologics have revolutionized the treatment of autoimmune diseases due to their efficacy, speed of onset, and tolerability. The development of new agents and expanded use of existing agents continues to be a highly active area of investigation among rheumatic diseases, with a multitude of innovative therapeutic strategies in various stages of development. Although the story of treatments continues rapidly, therapeutic research in some conditions is hindered by the rarity of the disease, variation in phenotype, and concerns about toxicity. This fast-paced development of therapeutics necessitates immediate investigation of individual biologic possibilities and therapeutic symptoms to best use these new treatment regimens. This handbook serves as a concise compendium to the modern therapeutic developments in the field. It will benefit clinicians, apprentices, support staff, and healthcare professionals working in rheumatology.